The government for the first time revealed how many people have signed up for HealthCare.gov plans during a special enrollment period.» Read More
Large employers could find themselves facing worker lawsuits for violating health-reform laws under the Affordable Care Act.
Much of the influenza virus in the U.S. has mutated and this year's vaccine doesn't provide good protection against it, NBC News reports.
A deadly epidemic that could have global implications is quietly sweeping India, and among its many victims are tens of thousands of newborns dying. The New York Times reports.
A lawsuit accuses drug maker Sanofi and top executives, including its ousted CEO, of a million-dollar kickback scheme to promote diabetes drug sales.
Business has slowed down on HealthCare.gov, the federal Obamacare health insurance marketplace, data shows.
As Equinox expands overseas and integrates its acquisition of LA Fitness, the gym chain's president explains strategy and what's changing the industry.
Honeywell CEO David Cote was surprised by the EEOC lawsuit regarding his company's wellness program, which the Obama administration encourages.
Johnson & Johnson has hired Goldman Sachs to explore a sale of its artificial sweetener Splenda, sources familiar with the matter told Reuters.
Biogen Idec said its experimental medicine for Alzheimer's disease showed promise, prompting it to move "aggressively" into the most advanced stage of studies.
Fatalities, infections and other "hospital-acquired conditions" have plunged, and Obamacare may have helped, health officials say.
Ebola was just a wake-up call for a more serious health threat, says Barry I. Eistenstein, a doctor and senior VP at Cubist Pharmaceuticals.
Google-backed genetic testing service 23andMe is launching in the U.K., with the CEO pledging that data would not be shared with Google.
A report suggests that traffic at the Obamacare market that offers insurance to employees of small businesses is off to a less-than-inspiring start.
GSK will ax hundreds of U.S. jobs in its biggest market as the drugmaker starts implementing a major cost-saving program.
Pfizer's attempt to take over AstraZeneca through a $110 billion bid would have run aground on changes to U.S. tax laws, even if the companies had reached a deal.
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects, scientists reported on Wednesday.
Less than a month into Obamacare's second open-enrollment season, HHS Secretary Sylvia Mathews Burwell says "we're off to a solid start."
Pfizer’s $110 billion bid for AstraZeneca was one of the biggest business stories of 2014 – so could a new bid be one of the biggest stories in 2015?
Up to 5 million undocumented immigrants may find getting affordable health care tough despite a presidential executive order to stop deportations.
Hundreds of families from across the country have relocated or are considering moving to a state where medical marijuana is legal.
Get the best of CNBC in your inbox